CD44 and breast carcinoma: Breast CSCs were first observed by Al Hajj et al., who described the existence of a subpopulation of CD44+CD24lowESA+lineage− human breast cancer cells capable of initiating tumors in immune-deficient NOD/SCID mice [8].